Archives

Alzheimer’s Clinical Study Info

My mom had early-Alzheimers before passing away in 2015. I know this affects so many people. Are you concerned about #MemoryLoss with a loved one in your life? New research options may be available. Researchers are testing potential new treatments that may help slow the progression of early #Alzheimers. If you are concerned about your #memory loss or someone in your life, you may be able to help by volunteering for a clinical
 

New Study for People with Mild to Moderate Alzheimer’s Disease

The purpose of this study is to investigate whether the study medication can help people with mild to moderate Alzheimer’s Disease improve their mental abilities such as understanding, reasoning, and judgment. The study medication will be given together with an FDA-approved Alzheimer’s medication: Aricept® (donepezil), Exelon® (rivastigmine) or Razadyne® (galantamine).

More about the study:

  • The study drug (MK-7622) is administered in the form of one capsule a day in the morning.
  • There will be 830
 

New Study for People with Severe to Very Severe COPD

This research study is testing whether a new investigational drug that targets eosinophils (a type of white blood cell) could help patients with COPD (chronic obstructive pulmonary disease) control symptoms and reduce exacerbations (flare-ups) that lead to hospitalizations. The new investigational drug will be compared to oral and inhaled corticosteroids, the current standard of care for COPD.

More about the study:

  • The study drug (Benralizumab) is administered by Subcutaneous (under the skin) injection (SC).
  • There